Literature DB >> 8405154

Healthy individuals possess circulating antibodies against their indigenous faecal microflora as well as against allogenous faecal microflora: an immunomorphometrical study.

H Z Apperloo-Renkema1, T G Jagt, R H Tonk, D van der Waaij.   

Abstract

Healthy persons were shown to possess circulating antibodies of both IgA, IgG and IgM isotype directed against the bacteria of their faecal microflora, assessed by immunomorphometry. After removal, by absorption, of the fraction of antibodies directed against the autochthonous faecal bacteria or cross-reacting with allogenous faecal bacteria, there were still antibodies left directed against allogenous faecal bacteria of both the IgA, IgG and IgM isotype. However, relatively more antibodies of the IgA isotype appeared to be directed against allogenous bacteria than against indigenous faecal bacteria. Persons who reacted with specific antibodies to many bacteria of their own flora also tended to react specifically to bacteria in the allogenous microflora of the other volunteers. The patterns of antibodies directed to faecal bacteria of different morphologies (morphotypes) were unique for each individual.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405154      PMCID: PMC2271392          DOI: 10.1017/s0950268800056983

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  13 in total

1.  Circulating antibodies against faecal bacteria assessed by immunomorphometry: combining quantitative immunofluorescence and image analysis.

Authors:  H Z Apperloo-Renkema; M H Wilkinson; D van der Waaij
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

2.  Effects of ceftriaxone on faecal flora: analysis by micromorphometry.

Authors:  B C Meijer; G J Kootstra; D G Geertsma; M H Wilkinson
Journal:  Epidemiol Infect       Date:  1991-06       Impact factor: 2.451

3.  Morphometrical parameters of gut microflora in human volunteers.

Authors:  B C Meijer; G J Kootstra; M H Wilkinson
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

Review 4.  Beyond clonal selection and network.

Authors:  A Coutinho
Journal:  Immunol Rev       Date:  1989-08       Impact factor: 12.988

5.  The resident faecal flora is determined by genetic characteristics of the host. Implications for Crohn's disease?

Authors:  J P Van de Merwe; J H Stegeman; M P Hazenberg
Journal:  Antonie Van Leeuwenhoek       Date:  1983-06       Impact factor: 2.271

6.  Defined leukocyte antigens of chimpanzees: use of chimpanzee isoantisera for leukocyte typing in man.

Authors:  H Balner; A van Leeuwen; H Dersjant; J J van Rood
Journal:  Transplantation       Date:  1967-07       Impact factor: 4.939

7.  Immunological response of mice to members of the autochthonous intestinal microflora.

Authors:  M C Foo; A Lee
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

8.  Comparison of methods for the determination of beta-aspartylglycine in fecal supernatants of leukemic patients treated with antimicrobial agents.

Authors:  G W Welling
Journal:  J Chromatogr       Date:  1982-10-08

9.  Variations in the anaerobic faecal flora of ten healthy human volunteers with special reference to the Bacteroides fragilis-group and Clostridium difficile.

Authors:  G J Meijer-Severs; E van Santen
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-02

10.  Effect of twelve antimicrobial drugs on the colonization resistance of the digestive tract of mice and on endogenous potentially pathogenic bacteria.

Authors:  N Wiegersma; G Jansen; D van der Waaij
Journal:  J Hyg (Lond)       Date:  1982-04
View more
  2 in total

Review 1.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

2.  Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic.

Authors:  Marika Mikelsaar; Mihkel Zilmer
Journal:  Microb Ecol Health Dis       Date:  2009-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.